SCHEMBL623386

SCHEMBL623386

CCOc1ccc(C(N)CC)cc1OCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.48
LMNA P02545 3/20 0.48
KDM4E B2RXH2 2/20 0.44
MAPT P10636 2/20 0.44
GAA P10253 1/20 0.44
SLC6A4 P31645 1/20 0.44
TNF P01375 1/20 0.44
SMN1; SMN2 Q16637 5/20 0.41
HTT P42858 1/20 0.41
MAPK1 P28482 3/20 0.40
POLB P06746 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
HSD17B10 Q99714 2/20 0.40
HPGD P15428 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16865878 0.91 ALDH1A1 (0.50) ALDH1A1LMNAKDM4EMAPTGAA
SCHEMBL6423584 0.91 ALDH1A1 (0.50) ALDH1A1LMNAKDM4EMAPTGAA
SCHEMBL7099805 0.91 ALDH1A1 (0.50) ALDH1A1LMNAKDM4EMAPTGAA
SCHEMBL16865875 0.91 ALDH1A1 (0.50) ALDH1A1LMNAKDM4EMAPTGAA
SCHEMBL28103281 0.87 ALDH1A1 (0.44) ALDH1A1LMNAKDM4EMAPTGAA
SCHEMBL16865876 0.87 ALDH1A1 (0.41) ALDH1A1LMNAKDM4EMAPTGAA
SCHEMBL16649548 0.86 MAPT (0.44) ALDH1A1LMNAKDM4EMAPTGAA
SCHEMBL10361478 0.85 ALDH1A1 (0.48) ALDH1A1LMNAKDM4EMAPTGAA
Hydrochloric Acid SCHEMBL5108645 0.83 GAA (0.47) ALDH1A1LMNAKDM4EMAPTGAA
SCHEMBL6693234 0.82 PDE4A (0.50) ALDH1A1LMNATNFSMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105899508-B Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection 豪夫迈·罗氏有限公司 2017-07-04 CN disclosed
EP-2603215-A2 NOVEL D3 DOPAMINE RECEPTOR AGONISTS TO TREAT DYSKINESIA IN PARKINSON'S DISEASE Philadelphia Health and Education Corporation (US) 2013-06-19 EP disclosed
WO-2012021629-A2 NOVEL D3 DOPAMINE RECEPTOR AGONISTS TO TREAT DYSKINESIA IN PARKINSON'S DISEASE PHILADELPHIA HEALTH & EDUCATION CORPORATION (US) 2012-02-16 WO disclosed